CAS 82101-17-5

disodium (3E)-3-(2-{4-[(carboxylatomethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylate

Description:

Disodium (3E)-3-(2-{4-[(carboxylatomethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylate, with CAS number 82101-17-5, is a chemical compound characterized by its complex structure, which includes multiple functional groups such as carboxylate and hydrazine moieties. This compound typically exhibits properties associated with both organic and inorganic chemistry, including solubility in polar solvents due to the presence of ionic disodium groups. Its structure suggests potential applications in pharmaceuticals or as a biochemical reagent, particularly in areas involving enzyme inhibition or as a ligand in coordination chemistry. The presence of the hydrazine group may also indicate potential reactivity in condensation reactions or as a precursor for further chemical modifications. Additionally, the compound's stability and reactivity can be influenced by pH and environmental conditions, making it important to consider these factors in practical applications. Overall, this compound represents a unique intersection of various chemical functionalities, making it of interest in both research and industrial contexts.

Formula: C₁₆H₁₁N₃Na₂O₆

InChI: InChI=1/C16H13N3O6.2Na/c20-13-6-5-11(7-12(13)16(24)25)19-18-10-3-1-9(2-4-10)15(23)17-8-14(21)22;;/h1-7,18H,8H2,(H,17,23)(H,21,22)(H,24,25);;/q;2*+1/p-2/b19-11+;;

SMILES: c1cc(ccc1C(=O)NCC(=O)O)NN=C1C=CC(=O)C(=C1)C(=O)O.[Na].[Na]

Synonyms:

• 5-[[4-[(Sodiooxycarbonylmethyl)carbamoyl]phenyl]azo]-2-hydroxybenzoic acid sodium salt
• 5-(Carboxymethylcarbamoyl-4-phenylazo)salicylic acid (disodium)
• Benzoic acid, 5-((4-(((carboxymethyl)amino)carbonyl)phenyl)azo)-2-hydroxy-, disodium salt

Ipsalazide

CAS: 82101-17-5

Ipsalazide is a drug used to treat bowel disease. It is an amide that has been shown to have iontophoretic properties. Ipsalazide inhibits the production of prostaglandins and leukotrienes, which are inflammatory mediators in the intestine. Ipsalazide also reduces pain, cramps, and diarrhea from colitis and other inflammatory bowel diseases. Ipsalazide should not be administered orally because of its high oral toxicity (LD50 = 2 mg/kg).

Formula: C₁₆H₁₁N₃Na₂O₆

Purity: Min. 95%

Molecular weight: 387.25 g/mol

Ref: 3D-HDA10117

Ipsalazide

CAS: 82101-17-5

Ipsalazide is a novel salicylazosulfapyridine analog for the treatment of inflammatory bowel disease.

Formula: C₁₆H₁₁N₃Na₂O₆

Purity: 99.43%

Color and Shape: Solid

Molecular weight: 387.25

Ref: TM-T19379